Sven G Enterlein

Title: Sven G Enterlein: Innovator in Monoclonal Antibodies

Introduction

Sven G Enterlein is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotherapeutics, particularly in the development of monoclonal antibodies. His work focuses on addressing critical health challenges posed by filoviruses.

Latest Patents

Sven G Enterlein holds a patent for "Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins." This patent provides non-human primate-derived binding molecules, such as antibodies or antigen-binding fragments, that can bind to orthologous epitopes found on two or more filovirus species or strains. He has 1 patent to his name.

Career Highlights

Throughout his career, Sven has worked with various esteemed organizations. He has been associated with Integrated Biotherapeutics, Inc. and Leland Stanford Junior University. His expertise in monoclonal antibodies has positioned him as a key figure in the biotherapeutics industry.

Collaborations

Sven G Enterlein has collaborated with notable professionals in his field, including Mohammad Javad Aman and Frederick Wayne Holtsberg. These collaborations have further enhanced his research and development efforts.

Conclusion

Sven G Enterlein's innovative work in monoclonal antibodies represents a significant advancement in the fight against filoviruses. His contributions continue to impact the field of biotherapeutics positively.